FDA.reportPublic FDA data

Application 018631

Type
NDA
Sponsor
US PHARM HOLDINGS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRENTALPENTOXIFYLLINETABLET, EXTENDED RELEASE;ORAL400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
11251SUPPL2016-02-17
15050SUPPL2016-01-20
33526SUPPL2015-03-27
15049SUPPL2015-02-17
976SUPPL2014-04-18
33525SUPPL2012-07-10
977SUPPL2012-07-09
33524SUPPL2005-04-12
975SUPPL2005-04-12
974SUPPL2003-10-09
20137SUPPL1997-04-29